Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2023-10-04 00:00:00 ET · period of report 2023-10-02 · accession 0001127602-23-025520 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| E | 2023-10-04 | 2023-10-02 | DNA | HENRY CHRISTIAN O | Dir | S - Sale | $4,499.00 | -4,499 | 1.24M | -0.4% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-10-02 | S | D | 4,499 | $4,499.00 | 1,238,878 | D | — | — |